Key result
Cyclosporin A decreases maximal ryanodine binding and increases dissociation constant in rat cardiac sarcoplasmic reticulum.
Why the study?
Chronic cyclosporin A treatment was reported to induce reversible alterations of contractile properties in rat hearts, but the underlying molecular mechanisms remained to be defined.
Does cyclosporin A alter the characteristics of the Ca2+-release channel in cardiac sarcoplasmic reticulum in rats?
Does cyclosporin A alter the characteristics of the Ca2+-release channel in cardiac sarcoplasmic reticulum in rats?
Answers are grounded in this paper and cite their sources.
Cyclosporin A induces heart muscle-specific alterations of the Ca2+-release channel, likely via calcineurin upregulation, which may explain its effects on cardiac contractile properties.
Chronic treatment with cyclosporin A (CsA) has been reported (H. S. Banijamali, M. H. ter Keurs, L. C. Paul, and H. E. ter Keurs. Cardiovasc. Res. 27: 1845-1854, 1993; I. Kingma, E. Harmsen, H. E. ter Keurs, H. Benediktsson, and L. C. Paul. Int. J. Cardiol. 31: 15-22, 1991) to induce reversible alterations of contractile properties in rat hearts. To define the molecular mechanisms underlying the physiological alterations, the Ca2+-release channel (CRC) and Ca2+-ATPase from sarcoplasmic reticulum in rats were examined. Ryanodine binding to whole homogenates of rat hearts shows time- and dose-dependent alterations in CRC properties by CsA. On 3 wk of treatment with 15 mg CsA. kg body wt-1. day-1, 1) maximal ryanodine binding (Bmax) decreased, 2) the dissociation constant of ryanodine (Kd) increased, 3) caffeine sensitivity of CRC increased, and 4) ruthenium red sensitivity of CRC decreased. On the other hand, Bmax and Kd of ryanodine binding in rat skeletal muscles were not changed. Ryanodine-sensitive oxalate-supported Ca2+ uptake in whole homogenates was lower in CsA-treated rat hearts than in control hearts, whereas total Ca2+ uptake in the presence of 500 M ryanodine was not changed. Functional experiments with rapamycin and Western blot analysis suggest that the CsA-induced alteration of ryanodine binding is due at least in part to an upregulation of calcineurin. The heart muscle-specific alterations of CRC could be responsible for the previously reported contractile changes of CsA-treated rat hearts.
No takes yet. Share an insight, caveat, or question.
Park et al. (1999) studied this question. Cyclosporin A vs. control was evaluated on ryanodine binding (Bmax) and dissociation constant (Kd). Cyclosporin A treatment in rats decreased maximal ryanodine binding and increased the dissociation constant of ryanodine in cardiac sarcoplasmic reticulum.
Synapse has enriched 10 related papers. Consider them for comparative context: